Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 10309

1.

Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer.

Ohara N, Kobayashi M, Ikeda Y, Hoshi T, Morita S, Kanefuji T, Yagi K, Suda T, Takada T, Hasegawa G, Sato Y, Hirano K, Kosugi SI.

Intern Med. 2019 Nov 8. doi: 10.2169/internalmedicine.3208-19. [Epub ahead of print]

2.

Elevated β-cell stress levels promote severe diabetes development in mice with MODY4.

Trojanowki B, Salem HH, Neubauer H, Simon E, Wagner M, Dorajo R, Boehm BO, Labriola L, Wirth T, Baumann B.

J Endocrinol. 2019 Nov 1. pii: JOE-19-0208.R1. doi: 10.1530/JOE-19-0208. [Epub ahead of print]

PMID:
31682591
3.

Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I.

Vieira R, Souto SB, Sánchez-López E, Machado AL, Severino P, Jose S, Santini A, Fortuna A, García ML, Silva AM, Souto EB.

Pharmaceuticals (Basel). 2019 Oct 10;12(4). pii: E152. doi: 10.3390/ph12040152. Review.

4.

Stratified Diabetes Mellitus Prevalence for the Northwestern Nigerian States, a Data Mining Approach.

Muhammad MU, Jiadong R, Muhammad NS, Nawaz B.

Int J Environ Res Public Health. 2019 Oct 24;16(21). pii: E4089. doi: 10.3390/ijerph16214089.

5.

Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.

Tomita Y, Iwadoh K, Ogawa Y, Miki K, Kato Y, Kai K, Sannomiya A, Koyama I, Kitajima K, Nakajima I, Fuchinoue S.

PLoS One. 2019 Oct 23;14(10):e0224203. doi: 10.1371/journal.pone.0224203. eCollection 2019.

6.

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands.

Hunt B, Malkin SJP, Moes RGJ, Huisman EL, Vandebrouck T, Wolffenbuttel B.

BMJ Open Diabetes Res Care. 2019 Oct 1;7(1):e000705. doi: 10.1136/bmjdrc-2019-000705. eCollection 2019.

7.

Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.

Goel R, Power D, Tchetche D, Chandiramani R, Guedeney P, Claessen BE, Sartori S, Cao D, Meneveau N, Tron C, Dumonteil N, Widder JD, Hengstenberg C, Ferrari M, Violini R, Stella PR, Jeger R, Anthopoulos P, Deliargyris EN, Mehran R, Dangas GD.

Int J Cardiol. 2019 Oct 11. pii: S0167-5273(19)31226-4. doi: 10.1016/j.ijcard.2019.09.063. [Epub ahead of print]

PMID:
31630816
8.
9.

Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method.

Febriyenti F, Rahmi S, Halim A.

J Pharm Bioallied Sci. 2019 Jul-Sep;11(3):262-267. doi: 10.4103/jpbs.JPBS_87_18.

10.

Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach.

Gu S, Lai LH.

Acta Pharmacol Sin. 2019 Sep 17. doi: 10.1038/s41401-019-0306-9. [Epub ahead of print]

PMID:
31530902
11.

A Prospective Study on the Effect of Corticosteroid Injection Dosage for Hand Disorders in Non-Insulin Dependent Diabetics.

Lekic N, Patel AA, Friend ME, Donnally CJ, Chen DL, Askari M.

Bull Hosp Jt Dis (2013). 2018 Sep;76(3):198-202.

PMID:
31513524
13.

Fatal rooster attack.

Fronczek J, Byard RW.

Forensic Sci Med Pathol. 2019 Aug 20. doi: 10.1007/s12024-019-00159-6. [Epub ahead of print]

PMID:
31432454
14.

Inhibitory effect of saccharides and phenolic compounds from maize silks on intestinal α-glucosidases.

Alvarado-Díaz CS, Gutiérrez-Méndez N, Mendoza-López ML, Rodríguez-Rodríguez MZ, Quintero-Ramos A, Landeros-Martínez LL, Rodríguez-Valdez LM, Rodríguez-Figueroa JC, Pérez-Vega S, Salmeron-Ochoa I, Leal-Ramos MY.

J Food Biochem. 2019 Jul;43(7):e12896. doi: 10.1111/jfbc.12896. Epub 2019 May 15.

PMID:
31353692
15.

Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH; Research Group.

Diabetologia. 2019 Aug;62(8):1319-1328. doi: 10.1007/s00125-019-4928-8. Epub 2019 Jul 4. Review.

PMID:
31270584
16.

Impact of Diabetes Mellitus on Postoperative Complications Following Laparoscopic Hysterectomy for Benign Indications.

Corrigan KE, Vargas MV, Robinson HN, Gu A, Wei C, Tyan P, Singh N, Tappy EE, Moawad GN.

Gynecol Obstet Invest. 2019;84(6):583-590. doi: 10.1159/000501034. Epub 2019 Jun 18.

PMID:
31212286
17.

Graph-Based Predictive Modelling of Chronic Disease Development: Type 2 DM Case Study.

Derevitskii I, Funkner A, Metsker O, Kovalchuk S.

Stud Health Technol Inform. 2019;261:150-155.

PMID:
31156107
18.

Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review.

Tatalovic M, Lehmann R, Cheetham M, Nowak A, Battegay E, Rampini SK.

BMJ Open. 2019 Jun 1;9(5):e028914. doi: 10.1136/bmjopen-2019-028914.

19.

Long-term endocrine outcome of small for gestational age infants born to mothers with and without gestational diabetes mellitus.

Shorer DT, Wainstock T, Sheiner E, Landau D, Pariente G.

Gynecol Endocrinol. 2019 Nov;35(11):1003-1009. doi: 10.1080/09513590.2019.1616174. Epub 2019 May 22.

PMID:
31117838

Supplemental Content

Loading ...
Support Center